CEP57L1 and diabetes mellitus: In a cohort of cancer patients, KLF5, KLHL13, and CUL3 levels were lower, but CA and CEP57L1 were higher in cancer tissues, compared with noncancerous counterparts, which were more obvious in those with diabetes.